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Reperfusion injury is one of the most common com-
plications leading to prolonged morbidity. The sud-
den return of oxygenated blood to acutely ischaemic
muscle causes the generation and release of oxygen
free radicals and subsequent cellular injury. Failure
to anticipate or recognise this complication can lead
to the rapid development of compartment syn-
drome and myonecrosis. Treatment consists of fas-
ciotomy. Prevention of reperfusion injury is the
focus of much experimental research, but effective
drug regimens have not been established for clinical
practice.
Other long-term complications include the per-
sistence of sensory or motor impairment. Loss of
sensation in the toes and foot increases the likeli-
hood of development of neurotrophic ulceration.
Such ulcers are more common in the setting of
impaired motor function. A polyneuropathy is the
most common form of residual nerve impairment,
although selective damage to individual nerves has
been reported. The manifestations of nerve damage
include wasting of the small muscles of the foot
associated with painful dysaesthesias, leading to an
alteration in gait. Treatment consists of attempts at
pharmacological control of pain, bracing of the foot,
and physical therapy until neuromotor function




Although fasciotomy in every case would produce
unacceptable and unnecessary morbidity, in practice
it is often left too late. Compartment pressure meas-
ures have been employed to some advantage, but
there is disagreement on pressure criteria for pro-
ceeding with fasciotomy. After revascularisation, fas-
ciotomy also should be performed if there are signs
of increased ischaemia without evidence of reocclu-
sion. A long skin incision and opening of all com-
partments, including the deep posterior compart-
ment, are needed unless initial inspection shows no
muscle death or swelling.
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Recommendation 62: Fasciotomy in acute limb
ischaemia
Fasciotomy should be performed at the primary
procedure if the acute severe ischaemia has been
prolonged or if signs of increased compartment
pressure develop. This applies irrespective of how
the clot was removed.
Critical Issue 24: Predicting the requirement for
fasciotomy
There is a need for an easy and accurate test to pre-
dict which patients require a fasciotomy.
C 4.6
Treatment of the Underlying Lesion
Simply removing the occluding lesion, whether it is a
thrombus or an embolus, is unlikely to be successful as
the sole treatment. If the occlusion was caused by an
embolus, the source has to be identified and treated. If
the acute occlusion was caused by thrombosis super-
imposed on preexisting atherosclerosis, then this
underlying lesion also has to be treated to avoid a
recurrence of the acute occlusion. This may be accom-
plished by either an endovascular or and open surgical
technique, depending on the balance between durable
success and procedural risk. The results of PTA in the
literature are dependent on morphology of the lesion
and patient selection and the criteria used to define
technical and clinical success and patency. These are
well discussed in sections B 4.3, Endovascular
Procedures for Intermittent Claudication (p 582), D 4.6,
Aortoiliac Disease-Endovascular Treatment (p 5182),
D 4.9, Infrainguinal Lesions-Endovascular Treatment
(p 5192). In general, the choice of treatment of the
underlying lesion(s) should follow the same principles
outlined in section D. Thus, the choice of treatment of
an underlying lesion that caused the clot should be
separated from the choice of method of clot removal.
That is, thrombolysis should not lead to PTA of exten-
sive atherosclerotic disease, which is better treated by
surgery. Similarly, thrombectomy should not lead to
bypass of a discrete underlying stenosis, which is
amenable to PTA.
Recommendation 63: Treatment of underlying
lesionCs} in acute limb ischaemia
It is important to identify the underlying cause of
the acute limb ischaemia, for instance, the source of
emboli. Ideally this should be done before inter-
vention.
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Recommendation 64: Choice of treatment of under-
lying lesion<s)
After relief of acute limb ischaemia and establish-
ing its aetiology, the choice of treatment of the
underlying lesion should be similar to the choice of
treatment in the setting of chronic limb ischaemia
and not automatically linked to the method of clot
removal.
C4.7
Management of Graft Thrombosis
When considering late graft thrombosis, the main
goals are to remove the clot and correct the underlying
lesion that caused the thrombosis. Alteration in the
inflow and outflow arteries is usually caused by the
progression of atherosclerosis and should be treated
with either PTA or bypass grafting, as detailed else-
where. Lesions intrinsic to the graft are dependent on
the type of conduit. Venous bypass grafts may devel-
op stenoses, typically at the site of a valve.' After
thrombolysis and identification of the lesion, it may be
treated with either PTA or surgical revision, the latter
usually being favoured for its superior long-term
results.? Prosthetic grafts develop intimal hyperplasia,
typically at the distal anastomosis. These rubbery
lesions respond differently to PTA than do the typical
eccentric atherosclerotic plaque and do not yield as
durable results. This has led many surgeons to suggest
that treatment should be exposure of the involved
anastomosis, with graft thrombectomy and patch
angioplasty of the narrowed graft/artery anastomosis
or a simple extension graft.
C 4.8
Follow-up Care
All patients should be heparinised in the immediate
postoperative period. Roughly half of postoperative
deaths are caused by thromboembolic complications,
so patients should receive anticoagulant drugs from
the time of operation. This should initially be with
heparin (20,000-40,000 IU/ day) for 1 week, followed
by warfarin for at least 3 months.! Green et al- found a
31% in-hospital recurrence of embolism in those not
receiving coumarin derivatives versus 9% in those
who did receive anticoagulant. It should, however, be
mentioned that a more recent randornised study failed
to show any improvement in L-month results with
anticoagulation."
Whether to continue coumarin drugs longer term is
controversial. Elliott et al,6 in a long-term follow-up of
the Henry Ford Hospital experience, showed that
long-term anticoagulation resulted in a lower
embolism recurrence rate and a better survival. As
might be expected, embolism series are likely to show
a benefit to long-term anticoagulant therapy, whereas
studies in which cases of arterial thrombosis predom-
inate may not. Long-term anticoagulation is therefore
recommended for cases of arterial embolism, whenev-
er the source has been neither effectively controlled
nor identified. The source of an embolus should be
investigated, for instance, by echocardiography,
although often the cause remains obscure. Long-term
anticoagulation should be considered in arterial
thrombosis when, even after treatment, the risk of
rethrombosis is still significant based on the remaining
arterial lesions. Atrial fibrillation causing arterial
embolism requires long-term anticoagulation. Long-
term anticoagulation in these cases usually means life-
long, but it should be assessed individually in light of
the patient's coexisting disease.
Critical Issue 25: Long-term anticoagulation after
thromboembolectomy
There is a need for further information to deter-
mine whether long-term anticoagulation is useful
after successful thromboembolectomy in the
absence of a proven source of emboli.
C 4.9
Management of a Thrombosed Popliteal
Aneurysm
Thrombolysis alone is insufficient in these cases
because it is unlikely to completely clear the thrombus
from the aneurysm. More importantly, the thrombosis
will recur. Exclusion of the aneurysm with a surgical
bypass may be sufficient alone, in the few cases in
which there has been no extension of the thrombus or
ernbolisation into the run-off vessels. Thrombolysis
has to be used to reestablish the patency of the run-off
vessels followed as soon as possible by a bypass pro-
cedure. Reversed vein is a conduit of choice. If the
patient has a significant popliteal aneurysm on the
other side (large or thrombus-lined), then this should
be treated electively by surgery, because the final
results are far superior to treating thrombosed
aneurysms?
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Recommendation 65: Treatment of thrombosed
popliteal aneurysm
In thrombosed popliteal aneurysms causing acute
limb ischaemia with poor infrapopliteal runoff, ini-
tial treatment by intraarterial thrombolysis or distal
thrombectomy is indicated, followed by exclusion
of the aneurysm by a surgical bypass procedure.
C 4.10
Primary Amputation
Primary amputation is preferred for patients with pro-
longed irreversible ischaemia or if, in the judgment of
the clinician, revascularisation of the severely
ischaemic limb could jeopardise the patient's life (see
Figure 17 and D 4.17, Amputation, p 5225).8
C 4.11
Manageme':!t Algorithm
The management scheme proposed in Figure 24 is
based on (1) the severity of the acute limb ischaemia at
the time of presentation, determined by clinical evalu-
ation and Doppler study, as developed above into a
clinical classification; (2) the reality that the time and
place for angiography and the choice of the method of
clot removal will most often be determined by time
constraints related to the degree of urgency for revas-
cularisation-e-that is, the severity of ischaemia.
Additional considerations are (3) essentially all
patients need early heparin administration to avoid
clot propagation; (4) the choice of treatment of any
underlying lesion after clot removal should depend on
the morphology of the lesion itself and should be inde-
pendent of the method of clot removal. It should be
pointed out that although this algorithm may apply
under ideal circumstances, paths in this decision tree
may be blocked by existing local conditions, for exam-
ple, the unavailability of catheter-directed thrombo-
lytic therapy or of an open operating room. All
patients receive heparin early, as soon as it is deter-
mined by clinical examination and differential diagno-
sis that the problem is acute arterial thromboem-
bolism. The patients are then categorised on the basis
of clinical examination and Doppler study into one of
four previous described clinical categories, thus strat-
ifying them according to severity of ischaemia.
Class 1 patients, that is, with a clearly viable
leg, should have. formal angiography if they are
decided to ultimately require revascularisation.
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Revascularisation may be delayed until a more com-
plete evaluation is accomplished. In fact, although it
might be convenient and cost-saving to proceed with
therapy during the same admission, the same careful
deliberation should be used in such patients as with
critical limb ischaemia. One of the reasons that the
results of thrombolytic therapy are significantly better
within 2 weeks of the occlusion.
Class IIA, marginally threatened patients, should
also be sent for formal angiography in the anglo-
graphic suite. This should be done promptly and with
the patient under close surveillance in case of deterio-
ration. Both class I and IIA patients should undergo
catheter-directed lytic therapy at the time of arteriog-
raphy. Further treatment would depend on the ability
to gain access, the success of that therapy, and the
lesion uncovered (eg, nothing but anticoagulation,
PTA, bypass). Class lIB, immediately threatened,
patients should be taken promptly to the operating
theater to undergo surgical thromboembolectomy. The
adequacy of this procedure should be controlled by
intraoperative angiography. Depending on the com-
pleteness of clot removal, adjunctive lytic therapy may
be given by instillation or infusion. Again, further
therapy would depend on the nature of the underly-
ing lesion (eg, anticoagulation alone, PTA, bypass).
Fasciotomy may well be required in this group (see
earlier discussion in this section).
Class III patients are those with irreversible changes
that preclude salvage of a functional foot. These
should remain anticoagulated but undergo amputa-
tion once the level of amputation is apparent,
although systemic metabolic complications of
ischemic skeletal muscle may, in some circumstances,
require early amputation. Most of these patients not
only have profound ischaemia but will have present-
ed after significant delay. Attempted revascularisation
of such patients is not only fruitless but may be life
threatening. This is because of the reperfusion syn-
drome, with metabolic complications (acidosis, hyper-
kalemia), renal failure secondary to myoglobinuria,
pulmonary embolism, or cardiac failure or arrhyth-
mias. However, those with early profound ischaemia
should have attempted thromboembolectomy,
because the distinction between class IIA and class III
is difficult to make in the early hours after acute arte-
rial occlusion.
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Fig. 24. Ideal Management Algorithm for the Treatment of Acute Limb Ischaemia.
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